toxylact: a06ad14 pentaerythrityl

The first professional lActological database in the word

Drugs in ATC class A06AD14 (pentaerythrityl / pentaerythritol tetranitrate) are organic nitrate vasodilators with limited data in lactation, so breastfeeding use is generally approached with caution and individual risk–benefit assessment.medpedia.framar+2

Substance and ATC context

Pentaerythritol tetranitrate (often listed as pentaerithrityl or pentaerythrityl) is an organic nitrate used as a vasodilator in the management and prevention of angina and other ischemic heart conditions.rxlist+2
Despite being technically grouped under osmotic laxatives in the A06AD ATC chapter on the Framar site, its primary pharmacological action is on the cardiovascular system via nitric oxide–mediated vasodilation.sciencedirect+2

Pharmacology and toxicology

Pentaerythritol tetranitrate is a nitrate ester that releases nitric oxide, leading to relaxation of vascular smooth muscle and increased coronary blood flow.wikipedia+3
Clinically it is used for chronic angina prophylaxis and relief of attacks, and it has been studied for effects on endothelial function and ischemia–reperfusion injury, where it can preserve flow‑mediated vasodilation similarly to nitroglycerin.pubmed.ncbi.nlm.nih+2
Unlike some other organic nitrates, PETN appears less prone to tolerance development and has shown no reproductive or developmental toxicity in animal models at therapeutic exposures, although it is also a powerful explosive at high concentrations.ahajournals+2

Maternal safety considerations

Typical adverse effects reflect nitrate‑induced vasodilation and include headache, flushing, dizziness, orthostatic hypotension, tachycardia, and nausea.rxlist
Serious risks relate mainly to profound hypotension, particularly when combined with phosphodiesterase‑5 inhibitors (e.g. sildenafil, tadalafil, vardenafil) or in patients with severe anemia, recent myocardial infarction, or conditions with elevated intracranial or intraocular pressure.rxlist
Long‑term use may require nitrate‑free intervals to reduce tolerance, and treatment should be individualized in pregnancy and lactation when alternative anti‑anginal therapies are considered.sciencedirect+2

Pregnancy and developmental data (brief)

Animal data and clinical studies in high‑risk pregnancies suggest PETN can improve uterine perfusion and offspring blood‑pressure programming without clear reproductive toxicity at clinical doses.europepmc+3
Available follow‑up studies up to 12 months of age indicate favorable outcomes and acceptable maternal safety in these specialized settings, but the evidence base is still limited and focused on specific obstetric populations.facebook+2

Lactation: transfer and infant risk

There are no direct data on pentaerythritol tetranitrate concentrations in human milk, and authoritative sources state that it is unknown whether PETN passes into breast milk.synbase+1
Given its short half‑life and hemodynamic effects, clinically significant infant exposure is plausible but unquantified, so most references recommend cautious use during breastfeeding, with preference for agents with better lactation data when possible.infantrisk+2
If PETN is required because of maternal cardiovascular status, infants should be monitored for signs of nitrate exposure such as poor feeding, unusual lethargy, pallor, or hypotonia, and maternal dosing should be titrated to the lowest effective dose.synbase+2

Lactation risk characterization and recommendations

In the absence of measured milk levels or published infant case reports, PETN would generally be classified as a drug with unknown lactation risk, not absolutely contraindicated but not preferred for routine use in nursing mothers.infantrisk+2
For otherwise stable angina, alternative anti‑anginal strategies with better characterized lactation profiles (e.g. beta‑blockers such as metoprolol, certain calcium channel blockers) are usually preferred, reserving PETN for situations where its particular pharmacodynamic profile is needed.ncbi.nlm.nih+1
When PETN is used during lactation, coordinated care between cardiology and a perinatal pharmacology/lactation service (e.g. InfantRisk or a local teratology information service) is advisable to individualize exposure assessment and infant monitoring.ncbi.nlm.nih+1

Summary

Organic nitrate vasodilators in ATC A06AD14 (pentaerithrityl / pentaerythrityl tetranitrate) are indicated for the prevention and treatment of angina and certain ischemic cardiovascular conditions, acting by nitric oxide–mediated relaxation of vascular smooth muscle and improvement of coronary perfusion.medpedia.framar+2
Adverse effects are typical of nitrates (headache, flushing, dizziness, orthostatic hypotension, tachycardia), and clinically significant hypotension may occur, especially with concomitant phosphodiesterase‑5 inhibitors or in patients with severe anemia or recent myocardial infarction, making individualized risk assessment essential in pregnancy and breastfeeding.ahajournals+2
Data in pregnancy and lactation remain limited: PETN has shown favorable maternal–fetal outcomes and no reproductive toxicity in animal and selected human studies, but milk transfer is unstudied and infant exposure is uncertain, so use during breastfeeding should be cautious, preferably at the lowest effective dose with infant monitoring and consideration of alternative therapies when feasible.sciencedirect+5

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.